Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BEAM | Common Stock | Options Exercise | $546K | +39.9K | +103.37% | $13.68 | 78.5K | Jan 18, 2023 | Direct | F1, F2 |
transaction | BEAM | Common Stock | Sale | -$2.13M | -47.2K | -60.14% | $45.14 | 31.3K | Jan 18, 2023 | Direct | F2, F3, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BEAM | Stock Option (Right to Buy) | Options Exercise | $0 | -39.9K | -14.1% | $0.00 | 243K | Jan 18, 2023 | Common Stock | 39.9K | $13.68 | Direct | F1, F5 |
Id | Content |
---|---|
F1 | The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. |
F2 | Includes 308 shares acquired by the Reporting Person under the Beam Therapeutics Inc. ("BEAM") Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2022. |
F3 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.50, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
F5 | The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested. |